EMD Serono Research & Development Institute, Inc.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by EMD Serono Research & Development Institute, Inc.
RECRUITINGPhase 1NCT07166601
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid...
The purpose of this first-in-human study is to identify a recommend dose(s) for subsequent larger studies (recommended dose(s) for expansion, RDE), examining increasing doses of...
Sponsor: EMD Serono Research & Development Institute, Inc.Enrolling: 775 locations
Advanced Solid Tumor
RECRUITINGPhase 1NCT06641908
Anti-GD2 ADC M3554 in Advanced Solid Tumors
The purpose of this study is to establish the recommended doses and further evaluate the safety and preliminary antitumor activity of M3554 in participants with soft tissue...
Sponsor: EMD Serono Research & Development Institute, Inc.Enrolling: 5211 locations
Advanced Solid Tumor
RECRUITINGPhase 3NCT07355218
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active cutaneous manifestations of...
Sponsor: EMD Serono Research & Development Institute, Inc.Enrolling: 2022 locations
Systematic Lupus ErythematosusCutaneous Lupus Erythematosus